Biotricity announced plans for a direct-to-consumer program, HeartSecure, to support the 127M Americans at risk for heart disease. HeartSecure offers the first-of-its-kind, home-based cardiac screening service, empowering individuals to proactively check their heart health from the comfort of their homes. When launched, this groundbreaking home-based cardiac screening service will be a significant milestone for Biotricity, positioning the company for increased growth and market penetration in the $1.05B Home Heart Health market.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTCY:
- Biotricity files to sell 1.42M shares of common stock for holders
- Biotricity files $50M mixed securities shelf
- Biotricity announces partnerships with home-based diagnostic companies
- Biotricity announces ‘high demand’ for Biotres Pro
- Biotricity launches cardiac monitoring pilot program with hospital system